Quick10K

⚲

Nemus Bioscience

Filings

10-Q	2020-09-30	Filed 2020-11-06
S-1	2020-07-13	Public Filing
10-Q	2020-06-30	Filed 2020-08-13
10-Q	2020-03-31	Filed 2020-05-08
10-K	2019-12-31	Filed 2020-03-23
10-Q	2019-09-30	Filed 2019-11-14
10-Q	2019-06-30	Filed 2019-08-09
S-1	2019-06-04	Public Filing
10-Q	2019-03-31	Filed 2019-05-10
10-K	2018-12-31	Filed 2019-03-14
10-Q	2018-09-30	Filed 2018-11-14
10-Q	2018-06-30	Filed 2018-08-10
10-Q	2018-03-31	Filed 2018-05-15
S-1	2018-03-23	Public Filing
10-K	2017-12-31	Filed 2018-03-19
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-11
10-Q	2017-03-31	Filed 2017-05-12
10-K	2016-12-31	Filed 2017-03-10
10-Q	2016-09-30	Filed 2016-11-09
10-Q	2016-06-30	Filed 2016-08-12
10-Q	2016-03-31	Filed 2016-05-13
10-K	2015-12-31	Filed 2016-03-21
10-Q	2015-09-30	Filed 2015-11-12
10-Q	2015-06-30	Filed 2015-08-14
10-Q	2015-03-31	Filed 2015-05-13
10-K	2014-12-31	Filed 2015-03-27
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-09-15
10-Q	2014-04-30	Filed 2014-06-05
10-Q	2014-01-31	Filed 2014-03-17
10-K	2013-10-31	Filed 2014-01-27
10-Q	2013-07-31	Filed 2013-09-16
10-Q	2013-04-30	Filed 2013-06-27

Reports

8-K	2020-09-25
8-K	2020-08-07
8-K	2020-07-31
8-K	2020-06-17
8-K	2020-04-29
8-K	2019-12-17
8-K	2019-11-21
8-K	2019-11-19
8-K	2019-08-23
8-K	2019-08-21
8-K	2019-08-07
8-K	2019-05-24
8-K	2019-03-29
8-K	2019-03-25
8-K	2019-02-26
8-K	2019-02-01
8-K	2018-11-14
8-K	2018-11-01
8-K	2018-10-05
8-K	2018-07-31
8-K	2018-06-01
8-K	2018-04-30
8-K	2018-02-16
8-K	2018-02-13
8-K	2018-01-19
8-K	2017-12-28

Nemus Bioscience Financials

NMUS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2013-04-30	2013-07-31	2013-10-31	2014-01-31	2014-04-30	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	30	37	52	46	50	39	1,025	207	177	601	4,343	3,221	2,062	832	320	65	380	109	42	260	2,950	1,879	1,063	1,858	4,417	2,812	1,324
Accounts Receivable	32	29	25	35	35	27
Inventory
PP&E	69	47	47	47	47	96	12	21	19	17	16	13	21	17	13	10	7	5	3	1	2	5	4	3	3	3	2
Assets	134	129	146	141	123	168	1,126	348	469	821	4,542	3,511	2,350	1,081	692	323	617	484	343	557	3,158	2,042	1,166	1,957	4,725	3,080	1,725
Accounts Payable								409	388	286	132	125	137	183	387	275	227	679	990	101	99	12	46	16	168	73	207
Long-Term Debt						43
Liabilities	69	64	62	54	49	86	350	802	807	1,682	3,515	3,040	3,360	1,337	1,711	1,774	1,847	2,262	2,448	1,357	8,912	10,288	11,321	17,519	32,589	14,721	18,127
Stockholders' Equity	66	65	83	87	73	81	776	-454	-338	-861	-594	-892	-2,370	-1,615	-2,379	-2,914	-2,879	-2,927	-3,230	-3,570	-5,754	-8,245	-10,155	-15,562	-27,864	-11,641	-16,402


Income Statement ($'000)	2013-04-30	2013-07-31	2013-10-31	2014-01-31	2014-04-30	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D							195	32	37	43	152	343	135	460	81	263	92	61	89	70	25	-64	67		321	688	513
SG&A	4	5	16	9	7	9	663	466	873	1,313	744	811	1,085	1,022	776	649	1,288	670	673	917	1,226	1,080	978		1,194	1,083	990
Tax	1	-1	-0	0	1	0	1	3	1	0	0	0	0	0	0	0	2	2	-2	0		2	0		0	2	0
Net Income	2	-1	-5	4	-14	8	-859	-2,732	-910	-2,057	-1,183	-691	-1,685	573	-945	-1,120	-1,283	-703	-480	-628	-8,214	-2,662	-2,096		-14,774	15,905	-4,931


Cash Flow ($'000)	2013-04-30	2013-07-31	2013-10-31	2014-01-31	2014-04-30	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		7	-8	-4	3	8	-952	-1,762	-752	-568	-1,295	-1,114	-1,148	-1,230	-512	-663	-816	-271	-67	-2,144	-1,053		-816		-1,431	-1,605	-1,488
Cash Investing		5	22					45	0	0	-2	0	-11	0	0						-1		0
Cash Financing		-4	1	-2	0	49	1,991	1,938	721	992	5,038	-8				408	1,132	0	0	2,381	3,740		0		3,991	0	0